Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging is targeting significant revenue growth in the upcoming years thanks to its strategic shift towards preventive health care with its Nanox.ARC offering, as evidenced by its potential to generate ~$36M in revenue by 2026. Despite reporting a net loss in the recent year, the company has streamlined its manufacturing process and entered into partnerships with established regional players, such as Digital X-Ray Imaging, to accelerate the deployment and support of its imaging platform. However, the success of the company's revenue target will depend on the timing, activations, partner execution, and adoption of its technology, which carries risks such as clinical/regulatory, partnership and financial, commercial, legal and intellectual property, and market share.

Bears say

Nano X Imaging is facing significant challenges in converting distribution agreements into revenue, with a lack of progress on financing and execution adding to the uncertainty. Additionally, the company's reliance on partnerships for market expansion and revenue growth may lead to a prolonged sales cycle. This, combined with risks related to clinical/regulatory, financial, and market share, warrant a negative outlook for the company's stock.

Nano-X Imaging (NNOX) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Buy based on their latest research and market trends.

According to 3 analysts, Nano-X Imaging (NNOX) has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.